NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Smith PB, Smith MJ, Gonzalez D, et al. Safety and Pharmacokinetics of Multiple-Dose Intravenous and Oral Clindamycin in Pediatric Subjects with BMI ≥ 85th Percentile [Internet]. Bethesda (MD): National Institute of Child Health and Human Development (US); 2015 Oct 15.
Safety and Pharmacokinetics of Multiple-Dose Intravenous and Oral Clindamycin in Pediatric Subjects with BMI ≥ 85th Percentile [Internet].
Show details8.1. Primary Aim
Characterize the PK of multiple-dose IV clindamycin in overweight and obese children and adolescents.
8.2. Secondary Aims
- Characterize the PK of multiple-dose oral clindamycin in overweight and obese children and adolescents.
- Characterize the safety profile of clindamycin in overweight and obese children and adolescents.
- OVERALL OBJECTIVES - Safety and Pharmacokinetics of Multiple-Dose Intravenous an...OVERALL OBJECTIVES - Safety and Pharmacokinetics of Multiple-Dose Intravenous and Oral Clindamycin in Pediatric Subjects with BMI ≥ 85th Percentile
Your browsing activity is empty.
Activity recording is turned off.
See more...